A
Ashish Sarraju
Researcher at Stanford University
Publications - 52
Citations - 503
Ashish Sarraju is an academic researcher from Stanford University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 7, co-authored 26 publications receiving 220 citations. Previous affiliations of Ashish Sarraju include Cardiovascular Institute of the South & Harvard University.
Papers
More filters
Journal ArticleDOI
Lectin-Dependent Enhancement of Ebola Virus Infection via Soluble and Transmembrane C-type Lectin Receptors
Matthew Brudner,Marshall Karpel,Calli Lear,Li Chen,L. Michael Yantosca,Corinne Scully,Ashish Sarraju,Anna Sokolovska,M. Reza Zariffard,Damon P. Eisen,Bruce A. Mungall,Darrell N. Kotton,Amel Omari,I-Chueh Huang,Michael Farzan,Kazue Takahashi,Lynda M. Stuart,Gregory L. Stahl,Gregory L. Stahl,Alan Ezekowitz,Gregory T. Spear,Gene G. Olinger,Emmett V. Schmidt,Ian C. Michelow +23 more
TL;DR: It is demonstrated that MBL indeed enhances infection of Ebola, Hendra, Nipah and West Nile viruses in low complement conditions, and support the concept of an innate immune haplotype that represents critical interactions between MBL and complement component C4 genes and that may modify susceptibility or resistance to certain glycosylated pathogens.
Journal ArticleDOI
Finding missed cases of familial hypercholesterolemia in health systems using machine learning.
Juan M. Banda,Juan M. Banda,Ashish Sarraju,Fahim Abbasi,Justin Parizo,Mitchel Pariani,Hannah Ison,Elinor Briskin,Hannah Wand,Sebastien Dubois,Kenneth Jung,Seth A. Myers,Daniel J. Rader,Joseph B. Leader,Michael F. Murray,Kelly D. Myers,Katherine Wilemon,Nigam H. Shah,Joshua W. Knowles,Joshua W. Knowles +19 more
TL;DR: A classifier to identify potential FH patients using electronic health record (EHR) data at Stanford Health Care is effective in finding candidate patients for further FH screening and can lead to effective identification of the highest risk patients for enhanced management strategies.
Journal ArticleDOI
Appropriateness of Cardiovascular Disease Prevention Recommendations Obtained From a Popular Online Chat-Based Artificial Intelligence Model.
Ashish Sarraju,Dennis Bruemmer,Erik H. Van Iterson,Leslie Cho,Fatima Rodriguez,Luke J. Laffin +5 more
TL;DR: The authors examined the appropriateness of artificial intelligence model responses to fundamental cardiovascular disease prevention questions and concluded that the model responses were appropriate for the task of predicting cardiovascular disease in a clinical setting.
Journal ArticleDOI
Machine learning and atherosclerotic cardiovascular disease risk prediction in a multi-ethnic population.
Andrew Ward,Ashish Sarraju,Sukyung Chung,Jiang Li,Robert A. Harrington,Paul A. Heidenreich,Latha Palaniappan,Latha Palaniappan,David Scheinker,Fatima Rodriguez +9 more
TL;DR: Overall, ML models achieved comparable or improved performance compared to the PCE while allowing risk discrimination in a larger group of patients including PCE-ineligible patients, and may help bridge important gaps in ASCVD risk prediction.
Journal ArticleDOI
Tailoring Encodable Lanthanide-Binding Tags as MRI Contrast Agents
TL;DR: Structurally defined LBTs are used as the starting point for re‐engineering the first coordination shell of the lanthanide ion to provide for high contrast through direct coordination of water to Gd3+ (resulting in the single LBT peptide, m‐sLBT), a first step in expanding the current base of specificity‐targeted agents available.